Page 3 - கடுமையான பயோடெக் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from கடுமையான பயோடெக். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In கடுமையான பயோடெக் Today - Breaking & Trending Today

Gilead's Kite signs second blood cancer pact, this time with Appia Bio for up to $875M

Gilead's Kite signs second blood cancer pact, this time with Appia Bio for up to $875M
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

United States , Culver City , Appia Bio , Fierce Biotech , ஒன்றுபட்டது மாநிலங்களில் , கல்கர் நகரம் , கடுமையான பயோடெக் ,

GSK Sells Off Part of UK RD Site, Reinvests in Biotech and Life Sciences


According to a July 16, 2021, report from Fierce Biotech, GlaxoSmithKline (GSK) announced plans to sell 33 acres of its 92-acre R&D site in Stevenage, UK.
The proposed sale comes at a time of criticism over GSK s historically low investment in R&D. Through the sale, the company will unlock US $554 million in investments from a private sector developer that seeks to build a campus for biotech and other early stage life science companies.
The site already houses the Cell and Gene Therapy Catapult and Stevenage Bioscience Catalyst, Fierce Biotech reports, the latter of which is home to more than 40 companies. Developing 33 acres into a life science campus would significantly increase the number of start-ups that could be based there. ....

United Kingdom , Fierce Biotech , Gene Therapy Catapult , Stevenage Bioscience Catalyst , ஒன்றுபட்டது கிஂக்டம் , கடுமையான பயோடெக் , கீந் சிகிச்சை கவண் ,

Raleigh biopharma company hopes to have a new treatment for celiac disease

Jun. 4 RALEIGH Raleigh-based biopharmaceutical company 9 Meters Biopharma formed just over a year ago, and while slowed by the pandemic, hopes to make significant progress this year in proving the effectiveness of its treatment for celiac disease. About 1% of the global population suffers from celiac disease, which causes a damaging immune response to gluten in the small intestine, said 9 . ....

New York , United States , Tel Aviv , John Temperato , Drug Administration , Salix Pharmaceuticals , Fierce Biotech , Raleigh Based Innovate Biopharmaceuticals , Naia Rare , Triangle Business Journal , Innovate Raleigh , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , தொலைபேசி அவிவ் , சாலிக்ஸ் மருந்துகள் , கடுமையான பயோடெக் , முக்கோணம் வணிக இதழ் , புதுமை ராலே ,